ARTV - Artiva Biotherapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$37.50
DETAILS
HIGH:
$40.00
LOW:
$35.00
MEDIAN:
$37.50
CONSENSUS:
$37.50
UPSIDE:
400.67%
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.3 | 2.4 | 26.7 | 3.5 | 1.0 |
| Cost of Revenue | 0 | 0.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | (0.7) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.3 | 2.4 | 26.7 | 3.5 | 1.0 |
| Operating Expenses | ||||||||||||||
| R&D Expenses | 21.9 | 19.3 | 17.0 | 17.6 | 17.9 | 17.1 | 13.3 | 13.5 | 12.3 | 11.2 | 11.2 | 13.1 | 11.3 | 14.8 |
| SG&A Expenses | 5.0 | 5.1 | 4.9 | 5.3 | 4.9 | 5.1 | 5.0 | 4.8 | 3.9 | 3.6 | 3.2 | 2.8 | 4.1 | 3.9 |
| Other Expenses | 0 | (0.7) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 26.9 | 23.8 | 21.9 | 22.9 | 22.8 | 22.2 | 18.3 | 18.3 | 16.2 | 14.7 | 14.3 | 15.8 | 15.3 | 18.7 |
| Operating Income | ||||||||||||||
| Operating Income | (26.9) | (24.4) | (21.9) | (22.9) | (22.8) | (22.2) | (18.3) | (18.3) | (16.2) | (14.5) | (12.0) | 10.8 | (11.8) | (17.7) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.5 | 0 |
| Interest Income | 1.9 | 0.9 | 1.2 | 1.4 | 1.6 | 1.9 | 2.2 | 1.8 | 0.7 | 0.7 | 0.6 | 0.4 | 0 | 1.0 |
| Profitability | ||||||||||||||
| EBITDA | (23.6) | (22.9) | (20.1) | (20.9) | (20.6) | (19.7) | (8.6) | (16.8) | (17.2) | (13.4) | (11.3) | 11.8 | (10.2) | (16.1) |
| EBIT | (25.0) | (23.5) | (20.8) | (21.5) | (21.3) | (20.3) | (9.2) | (17.5) | (17.8) | (14.0) | (11.9) | 11.3 | (10.8) | (16.7) |
| Income Before Tax | (25.0) | (23.5) | (20.8) | (21.5) | (21.3) | (20.3) | (9.2) | (17.5) | (17.8) | (14.0) | (11.9) | 11.3 | (11.3) | (16.7) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0 | 0 | 0 |
| Net Income | (25.0) | (23.5) | (20.8) | (21.5) | (21.3) | (20.3) | (9.2) | (17.5) | (17.8) | (14.0) | (12.0) | 11.3 | (11.3) | (16.7) |
| Per Share Data | ||||||||||||||
| EPS (Basic) | -0.63 | -0.95 | -0.85 | -0.88 | -0.87 | -0.83 | -0.82 | -0.92 | -0.62 | -0.79 | -0.54 | 0.59 | -0.90 | -0.95 |
| EPS (Diluted) | -0.63 | -0.95 | -0.85 | -0.88 | -0.87 | -0.83 | -0.82 | -0.92 | -0.62 | -0.79 | -0.54 | 0.59 | -0.90 | -0.95 |
| Shares Outstanding | 39.4 | 24.7 | 24.4 | 24.5 | 24.4 | 24.3 | 24.4 | 24.3 | 23.3 | 17.6 | 20.4 | 19.0 | 17.6 | 17.6 |
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | |||||||||||
| Cash & Cash Equivalents | 301.5 | 21.0 | 26.7 | 25.5 | 28.5 | 30.4 | 40.2 | 55.9 | 34.2 | 48.2 | 53.5 |
| Short-Term Investments | 47.9 | 65.8 | 81.3 | 97.5 | 113.9 | 135.6 | 145.2 | 90.8 | 12.3 | 13.9 | 23.5 |
| Net Receivables | 0.1 | 0.6 | 0.8 | 0.9 | 0.0 | 1.0 | 0.1 | 0.7 | 1.5 | 1.7 | 1.8 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 1.4 | 3.9 | 5.7 | 6.7 | 3.0 | 3.1 | 3.2 | 1.7 | 2.0 | 1.1 |
| Total Current Assets | 352.3 | 88.7 | 112.7 | 129.5 | 149.1 | 170.0 | 188.6 | 150.6 | 49.7 | 65.9 | 79.8 |
| Non-Current Assets | |||||||||||
| Property, Plant & Equipment | 15.1 | 16.3 | 17.4 | 18.5 | 19.8 | 20.8 | 20.4 | 21.5 | 22.7 | 23.4 | 24.6 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0.5 | 0 | 0 | 0 | 53.0 | 0 | 0 | 0 |
| Other Non-Current Assets | 1.3 | 0.9 | 0.9 | 0.4 | 0.5 | 0.5 | 0.5 | 0.6 | 3.4 | 0.9 | 0.7 |
| Total Non-Current Assets | 16.4 | 17.2 | 18.3 | 19.3 | 20.3 | 21.3 | 20.9 | 75.0 | 26.2 | 24.3 | 25.3 |
| Total Assets | 368.6 | 106.0 | 130.9 | 148.9 | 169.4 | 191.3 | 209.6 | 225.6 | 75.9 | 90.2 | 105.1 |
| Current Liabilities | |||||||||||
| Account Payables | 0 | 2.3 | 0.4 | 0.8 | 1.2 | 2.0 | 1.1 | 1.2 | 0.8 | 1.5 | 0.6 |
| Short-Term Debt | 0 | 3.0 | 3.1 | 3.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.4 | 2.4 | 2.1 | 1.5 | 0.1 | 0.1 | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 14.6 | 10.9 | 13.1 | 11.1 | 10.8 | 12.2 | 12.3 | 13.3 | 10.8 | 10.4 | 12.2 |
| Non-Current Liabilities | |||||||||||
| Long-Term Debt | 0 | 7.2 | 7.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0.1 | 244.2 | 241.9 | 241.6 |
| Total Non-Current Liabilities | 6.5 | 7.2 | 7.9 | 8.5 | 9.6 | 10.3 | 10.7 | 11.3 | 256.2 | 254.5 | 254.9 |
| Total Liabilities | 21.1 | 18.1 | 21.0 | 19.6 | 20.4 | 22.5 | 22.9 | 24.6 | 267.0 | 264.8 | 267.1 |
| Stockholders' Equity | |||||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0 | 0 | 0 |
| Retained Earnings | (379.1) | (354.1) | (330.5) | (309.8) | (288.2) | (267.0) | (246.7) | (230.6) | (213.1) | (195.3) | (181.3) |
| Accumulated Other Comprehensive Income | (0.0) | (0.0) | 0.1 | 0.1 | 0.0 | 0 | (0.1) | 0.3 | 0.1 | 0.2 | 0.3 |
| Total Stockholders' Equity | 347.5 | 87.8 | 110.0 | 129.2 | 149.0 | 168.8 | 186.6 | 201.0 | (191.1) | (174.7) | (162.0) |
| Total Liabilities & Equity | 368.6 | 106.0 | 130.9 | 148.9 | 169.4 | 191.3 | 209.6 | 225.6 | 75.9 | 90.2 | 105.1 |
| Debt Metrics | |||||||||||
| Total Debt | 9.8 | 10.3 | 10.9 | 11.7 | 13.2 | 14.0 | 14.4 | 15.0 | 15.8 | 16.3 | 16.9 |
| Net Debt | (291.6) | (10.7) | (15.8) | (13.8) | (15.2) | (16.4) | (25.9) | (40.9) | (18.5) | (31.9) | (36.6) |
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Net Income | (48.5) | (23.5) | (20.8) | (21.5) | (21.3) | (20.3) | (16.1) | (17.5) | (17.8) | (14.0) | (12.0) | 11.3 | (11.3) | (16.7) |
| Depreciation & Amortization | 1.4 | 0.7 | 1.1 | 0.3 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 | 0.6 |
| Stock-Based Compensation | 3.5 | 1.6 | 1.6 | 1.6 | 1.5 | 2.1 | 2.2 | 1.9 | 1.5 | 1.4 | 1.4 | 1.4 | 2.5 | 1.8 |
| Change in Working Capital | 2.2 | 0.5 | (6.4) | 4.9 | (3.4) | (1.5) | (0.3) | 3.0 | (0.0) | (3.0) | (1.1) | (23.8) | (3.5) | 0.1 |
| Other Non-Cash Items | 0.2 | (0.2) | 9.7 | (4.5) | (0.5) | (0.7) | (1.0) | 0.3 | 2.1 | (0.1) | 0.4 | (0.2) | (0.0) | 0 |
| Operating Cash Flow | (41.3) | (20.9) | (14.7) | (19.2) | (23.0) | (19.8) | (14.7) | (11.6) | (13.7) | (15.1) | (10.7) | (10.7) | (11.8) | (14.2) |
| Investing Activities | ||||||||||||||
| Capital Expenditure | (0.7) | (0.2) | (0.4) | (0.6) | (1.1) | (0.5) | (0.1) | (0.1) | (0.5) | (0.0) | (0.6) | (0.2) | (0.6) | (1.9) |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (6.4) | (6.4) | (7.5) | (12.7) | (6.1) | (18.5) | (14.9) | (142.9) | (12.2) | (6.2) | (14.8) | (12.3) | (22.4) | 0 |
| Sales/Maturities of Investments | 40 | 22 | 24 | 29.6 | 28.2 | 29 | 13.9 | 12.4 | 14 | 16 | 12.8 | 12 | 2 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | 32.9 | 15.3 | 16.0 | 16.3 | 21.1 | 10.0 | (1.0) | (130.6) | 1.3 | 9.8 | (2.7) | (0.5) | (21.0) | (1.9) |
| Financing Activities | ||||||||||||||
| Net Debt Issuance | (0.0) | (0.0) | 0 | 0 | (0.0) | (0.0) | (0.0) | (0.0) | (0.1) | 0 | 0 | 0 | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | (4.2) | 166.5 | 0 | 0 | 0 | 0 | 0 | (0.0) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 283.1 | (0.2) | (0.1) | (0.0) | (0.0) | 0.3 | 4.2 | (2.6) | (1.5) | 0 | 1.0 | 23.4 | 0.0 | 0 |
| Financing Cash Flow | 283.2 | (0.1) | (0.1) | (0.0) | (0.1) | 0.2 | (0.0) | 163.9 | (1.6) | 0 | 1.0 | 23.4 | 0.0 | (0.0) |
| Cash Position | ||||||||||||||
| Net Change in Cash | 274.8 | (5.7) | 1.2 | (3.0) | (1.9) | (9.6) | (15.6) | 21.6 | (14.0) | (5.3) | (12.4) | 12.2 | (32.7) | (16.1) |
| Cash at Beginning | 27.2 | 26.7 | 26.0 | 28.9 | 30.9 | 40.5 | 56.1 | 34.5 | 48.5 | 53.8 | 66.1 | 54.0 | 86.7 | 102.8 |
| Cash at End | 301.9 | 21.0 | 27.2 | 26.0 | 28.9 | 30.9 | 40.5 | 56.1 | 34.5 | 48.5 | 53.8 | 66.1 | 54.0 | 86.7 |
| Free Cash Flow | (42.0) | (21.2) | (15.1) | (19.8) | (24.0) | (20.4) | (14.7) | (11.7) | (14.1) | (15.1) | (11.3) | (10.9) | (12.3) | (16.1) |
| Key Metrics | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.3 | 2.4 | 26.7 | 3.5 | 1.0 |
| Gross Profit | 0 | (0.7) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.3 | 2.4 | 26.7 | 3.5 | 1.0 |
| Operating Income | (26.9) | (24.4) | (21.9) | (22.9) | (22.8) | (22.2) | (18.3) | (18.3) | (16.2) | (14.5) | (12.0) | 10.8 | (11.8) | (17.7) |
| Net Income | (25.0) | (23.5) | (20.8) | (21.5) | (21.3) | (20.3) | (9.2) | (17.5) | (17.8) | (14.0) | (12.0) | 11.3 | (11.3) | (16.7) |
| EPS (Diluted) | -0.63 | -0.95 | -0.85 | -0.88 | -0.87 | -0.83 | -0.82 | -0.92 | -0.62 | -0.79 | -0.54 | 0.59 | -0.90 | -0.95 |
| Balance Sheet | ||||||||||||||
| Cash & Equivalents | 301.5 | 21.0 | 26.7 | 25.5 | 28.5 | 30.4 | 40.2 | 55.9 | 34.2 | 48.2 | 53.5 | |||
| Total Assets | 368.6 | 106.0 | 130.9 | 148.9 | 169.4 | 191.3 | 209.6 | 225.6 | 75.9 | 90.2 | 105.1 | |||
| Total Debt | 9.8 | 10.3 | 10.9 | 11.7 | 13.2 | 14.0 | 14.4 | 15.0 | 15.8 | 16.3 | 16.9 | |||
| Stockholders' Equity | 347.5 | 87.8 | 110.0 | 129.2 | 149.0 | 168.8 | 186.6 | 201.0 | (191.1) | (174.7) | (162.0) | |||
| Cash Flow | ||||||||||||||
| Operating Cash Flow | (41.3) | (20.9) | (14.7) | (19.2) | (23.0) | (19.8) | (14.7) | (11.6) | (13.7) | (15.1) | (10.7) | (10.7) | (11.8) | (14.2) |
| Capital Expenditure | (0.7) | (0.2) | (0.4) | (0.6) | (1.1) | (0.5) | (0.1) | (0.1) | (0.5) | (0.0) | (0.6) | (0.2) | (0.6) | (1.9) |
| Free Cash Flow | (42.0) | (21.2) | (15.1) | (19.8) | (24.0) | (20.4) | (14.7) | (11.7) | (14.1) | (15.1) | (11.3) | (10.9) | (12.3) | (16.1) |